Dostinex Tablets Summary of Product Characteristics SmPC emc

Cabergoline is used to treat hyperprolactinemia (high levels of prolactin in your body). High prolactin levels may be caused by a hormone problem or by a tumor in your pituitary gland. Cabergoline treats a high level of prolactin in the body of the patient by blocking the excessive production from the pituitary gland by giving the command to the brain to stop making and releasing the prolactin natural hormone from the pituitary gland. Postural hypotension can occur following administration of cabergoline, particularly during the first days of administration of cabergoline.

• During the first days of cabergoline administration, patients should be cautioned about re-engaging in activities requiring rapid and precise responses such as driving an automobile or operating machinery.
• It is very unusual for cabergoline to cause clinically significant heart problems, but you should alert your doctor if you developed shortness of breath or ankle swelling.
• After parturition, when the mother elects not to breast feed the infant or when breast feeding is contraindicated due to medical reasons related to the mother or the new-born.
• Cabergoline is used to treat hyperprolactinemia (high levels of prolactin in your body).
• No information is available about the interaction between cabergoline and other ergot alkaloids; therefore, the concomitant use of these medications during long-term treatment with cabergoline is not recommended.
• Should pregnancy occur during treatment, cabergoline is to be discontinued.

Some women with macroprolactinomas may be advised to continue cabergoline in pregnancy. Your endocrinologist will discuss specific recommendations with you. No information is available about the interaction between cabergoline and other ergot alkaloids; therefore, the concomitant use of these medications during long-term treatment with cabergoline is not recommended. Postural hypotension can occur following administration of cabergoline. Symptomatic hypotension can occur with cabergoline administration for any indication. The weekly dose may be given as a single administration or divided into two or more doses per week according to patient tolerability.

Clinical monitoring

This cabergoline medicine is safe for women who are pregnant and willing to pregnant. However, all the risks and benefits should be discussed with the doctor before taking https://www.cottaa.com/sustanon-250-steroid-understanding-its-uses-side/ this medicine. Your health expert will start with a low dose and based on your health level slowly hike the dosage level within several months to decrease side effects.

How do I find out more about the medicine I am purchasing?

In addition, cabergoline exerts a central dopaminergic effect via D2 receptor stimulation at oral doses higher than those effective in lowering serum PRL levels. The long lasting PRL-lowering effect of cabergoline is probably due to its long persistence in the target organ as suggested by the slow elimination of total radioactivity from the pituitary after single oral dose in rats (t½ of approximately 60 hours). In some cases, symptoms or manifestations of cardiac valvulopathy improved after discontinuation of cabergoline.

Important considerations for taking this drug

It will be valid for six months from the date of issue, unless your vet states a shorter time – so you have to request the medication before the expiry date. Prescriptions for certain scheduled drugs such as Tramadol or Phenobarbitone have to be fulfilled within 28 days. Serious reactions are possible, and immediate medical attention is required should this happen. Examples include unusual changes in vision, pain in the groin, lumps noticeable around the stomach, reduced urination and coughing. This list is complete, and it is possible that some reactions which have not been listed here may occur.